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T he immune system has been increasingly considered as an important player in the progression of hypertension with a major role for angiotensin II (AngII)-dependent pathways. 1 More experimental evidence indicates that subsets of T lymphocytes accumulate in the renal interstitial tissues and alter glomerular filtration rate, leading to further elevation of blood pressure (BP). 2 Consistent with these observations, inhibitory studies using immunosuppressant agents or genetic manipulation with T cells ameliorate BP elevation. 3, 4 However, participation of other immune cells in the pathogenesis of salt-induced hypertension is not well understood. Axl is a receptor tyrosine kinase that belongs to a TAM (Tyro3, Axl, Mertk) family of tyrosine receptors. 5 Growth arrest-specific protein 6 (Gas6) is a common ligand for the TAM family. 6 The Gas6/Axl pathway is highly regulated in chronic disorders, such as cancer, autoimmunity, and cardiovascular diseases. 7 Transcriptomic and genomic analyses of kidneys from Sabra rats showed that Axl is a candidate gene for salt-induced hypertension. 8 We 9 and others 10 have confirmed in global knockout mice the critical role for the Gas6/Axl pathway in deoxycorticosterone acetate (DOCA)-salt hypertension. Specifically, we showed that Axl affects vascular dysfunction and contributes to late phase of DOCA-salt hypertension. 9 In contrast, Gas6 is involved in kidney remodeling without any effect on BP levels in the same mouse model. 10 Leukocytes contribute to development of hypertension in the salt-sensitive Sabra rat. 11 However, the role of Axl in the immune system in the development of hypertension is not clear. This study was aimed to investigate the role of Axl in hematopoietic (bone marrow [BM]-derived cells) versus nonhematopoietic cells in the pathological processes during salt-dependent hypertension. Our results suggest that Axl plays distinct roles in immune cells at early versus late phases of DOCA-salt hypertension.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Abstract-The Gas6/Axl pathway regulates many cell functions and is implicated in hypertension. In this study, we aimed to investigate the role of Axl in immune cells on initiation and progression of salt-dependent hypertension. Deoxycorticosterone acetate (75 mg/60 days release)-salt hypertension was induced for 1 week or 6 weeks in Axl chimeras generated by bone marrow transplant to restrict Axl deficiency to hematopoietic or nonhematopoietic compartments. 
Results

Hypertension Development in Axl Chimeras
In our previous studies, we showed that global deletion of the Axl gene protects from elevation of systolic BP at the late phase of DOCA-salt hypertension. 9 Axl is expressed in immune cells and is important for multiple functions. 12 To address the role of Axl in immune cells in the development of hypertension, we generated Axl chimeras by BM transplant. Representative flow cytometry plots of CD45.1 + / CD45.2 + staining on peripheral blood confirmed successful generation of Axl chimeras 6 weeks after BM transplant ( Figure 1A) Figure 1B ). Taken together our data suggest that Axl in the hematopoietic compartment is essential for initiation of early BP changes and also for the late maintenance of salt-dependent hypertension.
Kidney Function in Axl Chimeras in Early Phase of Hypertension
A central role for immune cells in an increase in oxidative stress has been shown in development of renal disease and elevation of BP.
3 Therefore, we examined kidney structure and function 1 week after DOCA-salt. The absence of Axl in the Figure 2A ). In addition, albumin levels in the urine tended to be lower (P=0.06) in this group (7.5±3.5 versus ≈15 μg/mL). However, higher levels of reactive oxygen species (ROS) were noted in the glomeruli and cortex region (≈2-fold) of the kidneys from Axl −/− →Axl −/− and Axl +/+ →Axl −/− compared with Axl +/+ →Axl +/+ chimeras ( Figure 2B ). We found that relative ROS expression was significantly reduced in glomeruli (>5-fold) and the cortex (>3-fold) of the kidneys from Axl −/− →Axl +/+ chimeras ( Figure 2B ). The latter observation suggests that the lack of Axl in kidneys leads to compensatory mechanisms that increase ROS production in early phase of hypertension. Given the known roles for Gas6 in kidney pathology, 10 we examined Gas6 and Axl mRNA levels in the kidneys from Axl chimeras ( Figure S1 in the onlineonly Data Supplement). We found that Axl expression was dramatically reduced in Axl −/− recipients: Axl −/− →Axl −/− and Axl +/+ →Axl −/− ( Figure S1A and S1B). However, Gas6 levels were slightly elevated in these chimeras after 1 week of DOCAsalt ( Figure S1A versus S1B). These findings suggest that Axl in hematopoietic cells contributes to early phases of hypertension probably via affecting kidney function that leads to the initial increase in systolic BP. Also, global deletion of Axl may result in an increase in renal Gas6 that might cause greater ROS production in the kidneys and a compensatory increase in BP.
Characterization of Immune Changes in Axl Chimeras
To determine how Axl may alter immune function, we analyzed immune cell subsets in spleens and kidneys of Axl chimeras after 1 week of DOCA-salt ( Figure 3) . Analysis of the spleen provided the assessment of the immune changes in the chimeras before specific analysis of changes in the kidney. Total leukocytes (CD45.1 + versus CD45.2 + ) in the spleens were not significantly different but tended to be slightly higher (P=0.07) in Axl −/− compared with Axl +/+ genotypes ( Figure 3B ). These findings indicate that lack of Axl in the hematopoietic compartment does not affect immune cell repopulation compared with Axl +/+ chimeras.
Role of Axl in Accumulation of Immune Cells in Kidneys in Early Phase of Hypertension
Expression of Axl dramatically affected accumulation of leukocytes in kidneys after 1 week of DOCA-salt ( Figure 3C ). Specifically, we found that Axl −/− →Axl +/+ mice had a significantly higher percentage of donor BM-derived cells compared with other Axl chimeras 1 week after DOCA-salt ( Figure 3C Taken together, these data suggest that expression of Axl in BM-derived cells affects the presence of populations of innate and adaptive immune cells, and may determine kidney dysfunction during early phase of hypertension.
Cytokine and Chemokine Expression in Kidneys From Axl Chimeras
To gain insight into the potential mechanisms by which Axl regulates kidney inflammation, we evaluated cytokine/ chemokine and their receptors expression after 1 week of Table S1 ). We found that an equal number of genes were downregulated or upregulated in the kidneys from Axl −/− →Axl −/− versus Axl +/+ →Axl +/+ chimeras ( Figure 5A ). However, there were more downregulated genes in the kidneys from Axl −/− →Axl +/+ versus Axl −/− →Axl −/− or Axl +/+ →Axl +/+ chimeras ( Figure 5B and 5C). We performed pathway analyses to dissect possible immune cell functions based on the lists of differentially expressed genes across Axl chimeras (Tables S2-S4 ). Evaluation of the upregulated pathways showed no differences between global Axl −/− and Axl Figure 5B and 5C). Thus, we conclude that Axl expression is critical in immune cells for the upregulation of several inflammatory pathways in the kidneys during the early phase of hypertension.
Vascular Changes in Axl Chimeras During Late Phase of Hypertension
Previously, we showed that Axl −/− mice had lower systolic BP at 6 weeks after DOCA-salt attributable to decrease in vascular remodeling via increase in vascular apoptosis. 9 Morphological evaluation of the arteries from Axl chimeras is shown in Table S5 mice exhibited lower values of media area compared with other chimeras (P=0.6-0.9) in the mesenteric artery (Table  S5 ). The mesenteric artery remodeling index (media:lumen ratio) was significantly decreased in Axl −/− →Axl +/+ and Axl 
Discussion
This is the first study that shows differences in immune-specific mechanisms controlled by Axl during early versus late phases of salt-dependent hypertension. Here, we report that the expression of Axl in the hematopoietic compartment is critical for initiation of DOCA-salt hypertension and for altered kidney function in the early phase of hypertension. We also found that global Axl the early phase of DOCA-salt hypertension in the kidney. These immune cell changes are associated with altered kidney function and a change in inflammatory cytokines. Most importantly, expression of Axl is critical for upregulation of the proinflammatory cytokine, IFNγ, which regulates many immune pathways in the kidneys during early hypertension. Finally, expression of Axl in both hematopoietic and nonhematopoietic cells controls vascular changes and BP during late phase of DOCA-salt hypertension. Taken together, we uncovered a dual role of Axl in immune and nonimmune cells in initiation and progression of salt-dependent hypertension ( Figure S2 ). Genetic mapping studies in rat salt-sensitive models (Dahl and Sabra) have identified a number of BP-related genes. 13 Axl is one of the candidate genes for salt-induced hypertension in the Sabra rat. 8 It was shown in mouse experiments that the Gas6/Axl pathway is critical for salt-dependent hypertension.
9,10 Previously, we confirmed a pathogenic role for Axl in DOCA-salt hypertension using global knockout mice 9 where the lack of Axl reduced late phase of systolic BP elevation by decrease in vascular remodeling. In the present study, the BP time-course and kidney remodeling in Axl −/− →Axl −/− chimeras were very similar to that in Axl −/− mice, suggesting that the BM transplant procedure has no effect on progression of DOCA-salt hypertension in Axl mice. The Gas6/Axl pathway has been implicated in pathogenesis of several kidney diseases.
14 Proliferation of the mesangial cells is induced by Gas6 in the rat experimental model of glomerulonephritis. 15 Studies in knockout mice suggested that Gas6 plays a crucial role in the early stage of diabetic nephropathy. 16 It has also been shown that Gas6 −/− mice had reduced kidney remodeling without any effect on systolic BP in DOCA-salt model. 10 We observed that the relative right kidney weight to body weight tended to be lower (P=0.06) in Axl −/− →Axl +/+ versus Axl −/− →Axl −/− mice after 6 weeks of DOCA-salt (data not shown). Our new findings in Axl chimeras might explain the phenotypic differences between Gas6 −/− and Axl −/− mice in progression of salt-dependent hypertension. Upregulation of Gas6 and Axl in the kidneys was evident in patients with chronic inflammatory renal diseases. 17 In vitro stimulation of vascular smooth muscle cells or immortalized human mesangial cells with AngII induced Gas6 and Axl expression via NADPHoxidase. 17 A more recent clinical study 18 demonstrated that circulating Gas6 is associated with renal disease severity, and that Gas6 levels were inversely correlated with kidney function in patients with end-stage renal disease. Likewise, in recipient Axl −/− chimeras, the increases in kidney Gas6 mRNA During the past several years, immune cells have been increasingly implicated in pathogenesis of salt-sensitive hypertension by altering the glomerular filtration of kidney. 2 Although it is recognized that inflammation in renal tissues is responsible for hypertension, the exact contribution of specific subsets of immune cells in hypertension is still unclear. 19 The majority of data emphasize the role of T lymphocytes in hypertension. 1 Seminal studies in RAG1 −/− mice showed that lack of T cells prevented AngII or DOCA-salt hypertension. 4 Involvement of innate cells has also been indicated in DOCA-salt hypertension in rats. 20 Neutralization of polymorphonuclear leukocytes significantly reduced hypertension in Sabra rat. 11 Interestingly, we showed here that the balance of the monocyte/macrophage subsets seems to be altered in the absence of Axl. Thus, innate and adaptive immunity contributes to progression of salt-dependent hypertension. The Gas6/TAM pathways are involved in differentiation and function of innate immune cells and are implicated in autoimmune disorders. 12 Conversely, we found an increase in the accumulation of B and dendritic cells with decreased macrophages in chimeras that lack Axl in BM-derived cells. These immune changes were coupled with reduction in systolic BP and proteinuria during the early phase of hypertension in Axl −/− →Axl +/+ chimeras. Furthermore, Axl in the hematopoietic compartment regulates IFNγ in early hypertensive kidneys. IFNγ has been implicated in regulation of major interactions between the innate and adaptive immunity in AngII-induced cardiac remodeling. 21 Recent mouse studies documented the importance of cell specificity in IFNγ signaling on kidney injury after AngII infusion. 22, 23 Future investigations will be required to evaluate Axl-dependent mechanisms across immune cell populations in the kidney during the early phase of salt-induced hypertension.
We further confirmed the importance of the Axl signaling in antiapoptotic mechanisms in the arteries during the late phase of hypertension. Findings in Axl +/+ →Axl −/− and Axl −/− →Axl +/+ chimeras suggested that both hematopoietic and nonhematopoietic cells participate in late phase of DOCA-salt hypertension. Similar to the role of Axl in nonhematopoietic cells in carotid remodeling in response to low blood flow, 24, 25 we also found that Axl can affect immune activation of vascular cells by IFNγ. 25 In contrast to a recent report, 22 we found that Axl in immune cells regulates early DOCA-salt hypertension and kidney changes without any effect on the frequency of T lymphocytes, although we did not assess the function of the T cells that could be modified by the presence or absence of Axl. Taken together, our data suggest that initiation of salt-dependent hypertension depends on the distribution of innate and adaptive immune cells in the kidneys and is regulated by Axl. In addition, Axl-dependent interactions of immune cells with the vasculature are critical in the late phase of hypertension.
Perspective
Expression of Axl in the hematopoietic compartment affects accumulation of several subsets of immune cells and proinflammatory cytokines that determine kidney function during early phase of salt-dependent hypertension. These early changes in the kidney that have been revealed with Axl deletion only in the immune system suggested that some compensatory mechanisms must exist in the global Axl −/− mice, which might be linked to enhanced Gas6 expression. We provide new insights on immune-driven mechanisms during early versus late phases of salt-dependent hypertension. Future studies will help to clarify the role of Axl in interactions among distinct immune cell types in salt-dependent hypertension.
Materials and Methods
Animals
Axl knockout (Axl-/-) mice were used from our colony (express CD45.2 alloantigen in bone marrow (BM) cells). B6.SJL Ptprc a Pep3 b / BoyJ mice (express CD45.1 alloantigen in BM cells) were purchased from Jackson Laboratory, bred in house and used as wild types (Axl+/+) 1 . All experiments were conducted in male mice (6weeks old) and were approved by the University of Rochester Animal Care Committee in accordance with the Use of Laboratory Animals guidelines of the National Institutes of Health and American Heart Association (UCAR #2003-206R).
Bone marrow transplant Bone marrow transplant (BMT) experiments between Axl+/+ and Axl-/-were done as we recently described 1 . Donor-derived BM cells (Axl+/+ or Axl-/-) were injected (6×10 6 ) into recipient mice after irradiation. Chimeric mice were allowed to recover for six weeks before experimentation.
A model of DOCA-salt hypertension We used a previously described DOCA-salt mouse model of hypertension 2 . Briefly, upon successful engraftment of the donor BM (>90%) Axl chimeric mice were anesthetized with a cocktail of ketamine and xylazine (130 and 9 mg/kg, i.p.). An incision was made to expose the left kidney, which was ligated and removed. At the time of surgery a 75mg DOCA pellet (60 days release, Innovative Research of America, USA) was placed subcutaneously in a lateral area on the back of chimeras. Subsequently, animals were injected with analgesic Flunixin meglumine (120mg/kg, i.p.) and given regular chow and a 1% NaCl solution as a drinking water. Systolic BP was measured weekly for 6week time-course using a non-invasive tail-cuff method plethysmography (Visitech System, USA). Kidney function in Axl chimeras was measured after 1week after induction of DOCA-salt. Total protein (Bradford assay) and albumin (ELISA kit, Exocell, USA) were measured in urine samples from Axl chimeras that were collected in metabolic cages for 24hrs.
Isolation of immune cells from peripheral tissues
Peripheral blood was collected into heparinized tubes from the mandibular vein and incubated with ACK lysis buffer for 5min to lyse the erythrocytes. Splenocytes were obtained by tearing the spleen in a 70µm cell strainer. Kidneys from Axl chimeras were harvested, placed in the 100µm cell strainer (BD Falcon) and mashed in RPMI media supplemented with 10% FBS (Hyclone). The resulted homogenates were centrifuged (1,300rpm, 4°C, 6min) and the cell pellet was re-suspended in RPMI media with 1% FBS, 100µg collagenase (Worthington) and incubated for 30min at 37°C in a fully humidified atmosphere with 95% O 2 /5% CO 2 . The digested solution was again centrifuged and the pellet with cells was gently re-constituted in 1mL PBS with 3% FBS.
Flow cytometry
The engraftment of donor BM cells was confirmed by staining of the blood samples after recovery period (6wk) with a cocktail of CD45.1-FITC and CD45.2-PE antibodies (1:500, eBiosciences) and analyzed using 4-color BD Accuri C6 flow cytometer (BD Biosciences). Five major subsets of immune cells were detected using 12-color LSRII flow cytometer (BD Bioscience) and shown in the Figure 3A . Isolated cells from spleen or kidney of Axl chimeras were first incubated with live/dead stain (1:500, Invitrogen). Following this step, the cells were washed with FACS buffer (1,200rpm, 4°C, 6min) and incubated with FC block (1:10, BD Bioscience) at room temperature for 30min. Then cells were stained with a cocktail containing CD45.1-FITC (1:1000, eBioscience), CD45.2-PE (1:500, eBioscience), CD3-APC (1:200, eBioscience), CD19-PE-CYC (1:500, eBioscience), CD11b-PE-CY5.5 (1:500, BD Bioscience), CD11c-PE-TXR (1:500, Invitrogen) and NK1.1-APC-CY7 (1:100, Biolegend) antibodies at 4°C for 30min. Cells were washed and re-suspended in FACS buffer. Compensation controls were prepared using anti-rat/hamster IgGκ beads for single stained controls and live/dead beads. Flow cytometry analyses were performed using FlowJo software version 7.6.3.
Quantitative RT-PCR In a separate set of Axl chimeras, left kidneys were harvested during surgery and right kidney after 1 week of DOCA-salt treatment and were immediately frozen in liquid nitrogen (Ref) . RNA was isolated and amplified to cDNA with a NuGEN (San Carlos, CA) Ovation RNA amplification system V2. The cDNA samples were assayed for Axl, Gas6, and GAPDH expression. Inflammatory cytokines and receptors were assessed using a mouse PCR Array (PAMM-011; Qiagen). The list of 84 studied genes is shown in Table S1 . Bioinformatics analyses of gene expression profiles from kidneys across Axl chimeras were performed as previously described 1 .
Morphometry and immunohistochemistry
Axl chimeras were perfusion fixed with 10% paraformaldehyde and histology was performed as described 2 . Apoptotic cells were detected in Axl chimeras with ApopTag peroxidase In situ Apoptosis Detection Kit (Chemicon Int) as reported 2 . Oxidative stress was assessed in the kidneys using OxyIHC Oxidative Stress Detection Kit (Millipore). We used MCID image software (MCID Elite 6.0, Imaging Research) for morphometry and ROS analyses as shown previously 3 .
Statistical analysis
Results are shown as means±SEM. Statistical differences were evaluated using JMP5.1.2 software. Differences between two groups were analyzed by pooled Student's t test. For more than 3 experimental groups we utilized one-way ANOVA or Wilcoxon test followed by post hoc comparisons. The level of p<0.05 was regarded as significant. Chemokine (C-C motif) receptor 9 Lta Lymphotoxin A Crp C-reactive protein, pentraxin-related Ltb Lymphotoxin B Cx3cl1
Chemokine (C-X3-C motif) ligand 1 Mif Macrophage migration inhibitory factor Cxcl1
Chemokine (C-X-C motif) ligand 1 Scye1 Small inducible cytokine subfamily E, member 1 Cxcl10
Chemokine (C-X-C motif) ligand 10 Spp1 Secreted phosphoprotein 1 Cxcl11
Chemokine (C-X-C motif) ligand 11 Tgfb1 Transforming growth factor, beta 1 Cxcl12
Chemokine (C-X-C motif) ligand 12 Tnf Tumor necrosis factor Cxcl13 Chemokine (C-X-C motif) ligand 13 Tnfrsf1a Tumor necrosis factor receptor superfamily, member 1a
Cxcl15
Chemokine (C-X-C motif) ligand 15 Tnfrsf1b Tumor necrosis factor receptor superfamily, member 1b Pf4
Platelet factor 4 Cd40lg CD40 ligand Cxcl5
Chemokine (C-X-C motif) ligand 5 Tollip Toll interacting protein Cxcl9
Chemokine (C-X-C motif) ligand 9 Xcr1 Chemokine (C motif) receptor 1 
